COCHLEAR LTD ADR 1/2/O.N. (OC50) - Total Assets
Based on the latest financial reports, COCHLEAR LTD ADR 1/2/O.N. (OC50) holds total assets worth €2.83 Billion EUR (≈ $3.30 Billion USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore OC50 long-term investments to assets to see how much of total assets are deployed in long-term investments.
COCHLEAR LTD ADR 1/2/O.N. - Total Assets Trend (2022–2025)
This chart illustrates how COCHLEAR LTD ADR 1/2/O.N.'s total assets have evolved over time, based on quarterly financial data. See OC50 net asset value for net asset value and shareholders' equity analysis.
COCHLEAR LTD ADR 1/2/O.N. - Asset Composition Analysis
Current Asset Composition (June 2025)
COCHLEAR LTD ADR 1/2/O.N.'s total assets of €2.83 Billion consist of 50.2% current assets and 49.9% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 9.8% |
| Accounts Receivable | €533.80 Million | 18.9% |
| Inventory | €499.40 Million | 17.7% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €222.20 Million | 7.9% |
| Goodwill | €278.60 Million | 9.9% |
Asset Composition Trend (2022–2025)
This chart illustrates how COCHLEAR LTD ADR 1/2/O.N.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of COCHLEAR LTD ADR 1/2/O.N..
Key Asset Composition Facts
- Current vs. Non-Current Assets: COCHLEAR LTD ADR 1/2/O.N.'s current assets represent 50.2% of total assets in 2025, a decrease from 53.8% in 2022.
- Cash Position: Cash and equivalents constituted 9.8% of total assets in 2025, down from 25.5% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 16.0% of total assets, an increase from 15.0% in 2022.
- Asset Diversification: The largest asset category is accounts receivable at 18.9% of total assets.
COCHLEAR LTD ADR 1/2/O.N. Competitors by Total Assets
Key competitors of COCHLEAR LTD ADR 1/2/O.N. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Edwards Lifesciences Corp
NYSE:EW
|
USA | $13.32 Billion |
|
DexCom Inc
NASDAQ:DXCM
|
USA | $6.63 Billion |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
|
China | CN¥805.10 Million |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
|
China | CN¥1.86 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Theradiag SA
PA:ALTHE
|
France | €11.55 Million |
|
Corentec Co Ltd
KQ:104540
|
Korea | ₩175.16 Billion |
|
Adherium Ltd
AU:ADR
|
Australia | AU$4.16 Million |
COCHLEAR LTD ADR 1/2/O.N. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.35 | 2.30 | - |
| Quick Ratio | 1.52 | 1.68 | - |
| Cash Ratio | 0.00 | 0.00 | - |
| Working Capital | €814.50 Million | €820.60 Million | - |
COCHLEAR LTD ADR 1/2/O.N. - Advanced Valuation Insights
This section examines the relationship between COCHLEAR LTD ADR 1/2/O.N.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.25 |
| Latest Market Cap to Assets Ratio | 1.65 |
| Asset Growth Rate (YoY) | 2.9% |
| Total Assets | €2.83 Billion |
| Market Capitalization | $4.65 Billion USD |
Valuation Analysis
Above Book Valuation: The market values COCHLEAR LTD ADR 1/2/O.N.'s assets above their book value (1.65x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: COCHLEAR LTD ADR 1/2/O.N.'s assets grew by 2.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for COCHLEAR LTD ADR 1/2/O.N. (2022–2025)
The table below shows the annual total assets of COCHLEAR LTD ADR 1/2/O.N. from 2022 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | €2.83 Billion ≈ $3.30 Billion |
+2.91% |
| 2024-06-30 | €2.75 Billion ≈ $3.21 Billion |
+6.87% |
| 2023-06-30 | €2.57 Billion ≈ $3.00 Billion |
+4.20% |
| 2022-06-30 | €2.47 Billion ≈ $2.88 Billion |
-- |
About COCHLEAR LTD ADR 1/2/O.N.
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor… Read more